RCT of a Written Action Plan vs. Usual Care in Children With Acute Asthma
Does the Use of a New Written Action Plan Increase Short-term Adherence to Prescribed Medication and Asthma Control in Children Treated for an Asthma Attack in the Emergency Department: A Randomized Controlled Trial.
1 other identifier
interventional
218
1 country
1
Brief Summary
The objective of the proposed large, high-intensity, randomised controlled trial is to evaluate the real-life effectiveness of providing a written action plan to asthmatic children discharged from the emergency department (ED) or hospital on the short-term adherence to written recommendations (including medication, attendance to asthma education and medical follow-up). main outcome is adherence to prescribed inhaled preventive medication measured by an electronic counter. Secondary outcomes include attendance to asthma education and to medical follow-up, serving by pharmacy of prescription of oral steroids, as well as asthma control measured by questionnaire (Asthma Quiz for Kidz),2 use of rescue ß2-agonists, relapse to emergency room.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2006
CompletedFirst Posted
Study publicly available on registry
September 27, 2006
CompletedStudy Start
First participant enrolled
October 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2007
CompletedMarch 27, 2014
March 1, 2014
6 months
September 25, 2006
March 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence rate to daily inhaled steroids, reported as the ratio of the sum of number of recorded over prescribed activation per day during the 28 days following the index visit.
Secondary Outcomes (8)
Proportion of children filling their prescription of oral steroids
Use of rescue B2-agonists measured by dose counter
Quality of life in children aged 7 years and older, measured by the Juniper Questionnaire
Quality of life of their parent, measured by the Juniper Questionnaire
Asthma control, measured by the Asthma Quiz for Kidz
- +3 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Children will be eligible, whether they are discharged from the ED or following a hospital admission, if:
- aged 1 to 17 years;
- presenting with acute asthma as per the 2003 Canadian Consensus Statement - The ED physician will be responsible for confirming the diagnosis of asthma;
- requiring at least one nebulisation of salbutamol;
- the ED physician plans on prescribing the patient inhaled steroids and/or inhaled b2-agonists delivered by metered dose inhaler or continuing a previously prescribed inhaled steroid;
- the patient intends to stay in the Province of Quebec in the next 45 days;
- the patient (and their parents) have a good understanding of written and spoken French or English.
You may not qualify if:
- Children will be excluded if they:
- currently take asthma medications (ß2-agonist and/or inhaled steroids) using a turbuhaler or diskus, because these delivery devices cannot be fitted with Doser CT, a computerized electronic dose counter for metered dose inhalers;
- have another chronic lung disease (other than asthma) such as cystic fibrosis or bronchopulmonary dysplasia;
- have known hypersensitivity to inhaled salbutamol or fluticasone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ste-Justine Hospital
Montreal, Quebec, H3T 1C5, Canada
Related Publications (1)
Ducharme FM, Zemek RL, Chalut D, McGillivray D, Noya FJ, Resendes S, Khomenko L, Rouleau R, Zhang X. Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med. 2011 Jan 15;183(2):195-203. doi: 10.1164/rccm.201001-0115OC. Epub 2010 Aug 27.
PMID: 20802165DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francine M. Ducharme, MD, MSc
CHUS-Ste Justine Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 25, 2006
First Posted
September 27, 2006
Study Start
October 1, 2006
Primary Completion
April 1, 2007
Last Updated
March 27, 2014
Record last verified: 2014-03